Khammari, Amir

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Martens, A., Wistuba-Hamprecht, K., Foppen, M. G., Yuan, J., Postow, M. A., Wong, P., Romano, E., Khammari, A., Dreno, B., Capone, M., et al. (2016) · Clinical Cancer Research

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 541

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab

Martens, A., Wistuba-Hamprecht, K., Yuan, J., Postow, M. A., Wong, P., Capone, M., Madonna, G., Khammari, A., Schilling, B., Sucker, A., et al. (2016) · Clinical Cancer Research

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 180

Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients

Wistuba-Hamprecht, K., Martens, A., Heubach, F., Romano, E., Geukes Foppen, M., Yuan, J., Postow, M., Wong, P., Mallardo, D., Schilling, B., et al. (2017) · European Journal of Cancer

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 108

A Salicylic Acid-Based Dermocosmetic is Effective as an Adjunct to Benzoyl Peroxide for Mild to Moderate Acne and as Monotherapy in Maintenance Post Benzoyl Peroxide

Khammari, A., Demessant-Flavigny, A. L., Kerob, D., Seite, S., & Dreno, B. (2023) · Journal of Drugs in Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 14

Patients at elevated risk of melanoma: Individual predictors of non-compliance to GP referral for a dermatologist consultation

Rat, C., Quereux, G., Monegier du Sorbier, M., Gaultier, A., Bonnaud-Antignac, A., Khammari, A., Dreno, B., & Nguyen, J. M. (2014) · Preventive Medicine

Cutaneous Melanoma Detection and ManagementGlobal Cancer Incidence and Screening

Cited by 14

26274 A dermocosmetic used in combination with the fixed combination adapalene 0.1% and benzoylperoxide 5% helps to protect the skin barrier in mild to moderate acne

Dréno, B., Khammari, A., & Duhamelle, K. (2021) · Journal of the American Academy of Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 1